newbiotherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | NewBioNewBio |
| Description | TEL : 021-12345668 中 文 | ENGLISH ABOUT R&D PIPELINE MEDIA HR CONTACTS NewBio Therapeutics, Inc. is an innovative bio-tech company located in the Zhangjian |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 116.228.89.88 |
| Location | China |
Related Websites
| Site | Rank |
More to Explore
newbiotherapeutics.com Valuation
|
US$455,834
Last updated: 2022-10-08 15:34:10
newbiotherapeutics.com has Semrush global rank of 23,219,688. newbiotherapeutics.com has an estimated worth of US$ 455,834, based on its estimated Ads revenue. newbiotherapeutics.com receives approximately 52,597 unique visitors each day. Its web server is located in China, with IP address 116.228.89.88. According to SiteAdvisor, newbiotherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$455,834 |
| Daily Ads Revenue | US$421 |
| Monthly Ads Revenue | US$12,624 |
| Yearly Ads Revenue | US$151,477 |
| Daily Unique Visitors | 3,507 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| newbiotherapeutics.com. | A | 3599 | IP: 116.228.89.88 |
| newbiotherapeutics.com. | NS | 86400 | NS Record: dns25.hichina.com. |
| newbiotherapeutics.com. | NS | 86400 | NS Record: dns26.hichina.com. |
| newbiotherapeutics.com. | MX | 600 | MX Record: 5 mxn.mxhichina.com. |
| newbiotherapeutics.com. | MX | 600 | MX Record: 10 mxw.mxhichina.com. |
| newbiotherapeutics.com. | TXT | 600 | TXT Record: v=spf1 include:spf.mxhichina.com -all |
HtmlToTextCheckTime:2022-10-08 15:34:10
| TEL : 021-12345668 中 文 | ENGLISH ABOUT R&D PIPELINE MEDIA HR CONTACTS NewBio Therapeutics, Inc. is an innovative bio-tech company located in the Zhangjiang Pharma Valley (Pudong, Shanghai). The company was founded on Feb. 18, 2011, with registered capital of 20 million yuan. Our R&D is focused on monoclonal antibody and antibody-drug conjugate (ADC) as anti-cancer therapeutics. All pipeline drug candidates are proprietary. Two programs are in phase I clinical trials, and five more programs are in either preclinical study or early discovery stages. NewBio has collaborat… 2016-02-08 NBT-UCLA collaboration[February 8, 2016] 2015-10-21 NewBio Therapeutics Attended the 6th World ADC Summit.[October 21,2015] 2015-04-10 Dr.Bruce Han attended the SLAS9 , and made a speech. [April 10,2015] Copy right NewBio Therapeutics @ 2022 沪ICP备14030585号 Website: http://www.newbiotherapeutics.com Zhangjiang High Technology Park Pudong District Shanghai Technical support : TIDE |
HTTP Headers
HTTP/1.1 200 OK Date: Mon, 01 Nov 2021 17:46:51 GMT Server: Connection: close Content-Type: text/html; charset=utf-8 Content-Length: 1392 Cache-Control: no-cache,must-revalidate Last-Modified: Tue, 28 Jul 2015 10:12:48 GMT |
newbiotherapeutics.com Whois Information
Domain Name: NEWBIOTHERAPEUTICS.COM Registry Domain ID: 1649484130_DOMAIN_COM-VRSN Registrar WHOIS Server: grs-whois.hichina.com Registrar URL: http://www.net.cn Updated Date: 2020-02-21T01:41:57Z Creation Date: 2011-04-06T11:46:54Z Registry Expiry Date: 2024-04-06T11:46:54Z Registrar: Alibaba Cloud Computing (Beijing) Co., Ltd. Registrar IANA ID: 420 Registrar Abuse Contact Email: DomainAbuse@service.aliyun.com Registrar Abuse Contact Phone: +86.95187 Domain Status: ok https://icann.org/epp#ok Name Server: DNS25.HICHINA.COM Name Server: DNS26.HICHINA.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-20T02:22:30Z <<< |